Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Lian

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Journal of Autoimmunity|February 1, 2024
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitisRui Wang, Qiuxiang Lin, Zhonghua Lu, et al.
Journal of Autoimmunity|February 3, 2019
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?Chunyan Sun, Xiao Xiao, Li Yan, et al.
Nature Communications|March 28, 2023
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expressionYou Li, Zhiqiang Li, Ruiling Chen, et al.
Clinical Reviews in Allergy & Immunology|June 9, 2026
Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score DevelopmentHaoyu Wen, Yu Chen, Qiuxiang Lin, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapyYu Chen, Haoyu Wen, You Li, et al.
Imeta|March 3, 2025
Gut microbiota in treating inflammatory digestive diseases: Current challenges and therapeutic opportunitiesYongpeng Shi, Zeran Chen, Tingyu Fang, et al.
Hepatology (Baltimore, Md.)|February 20, 2022
Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1You Li, Ying Sun, Yanmin Liu, et al.
Nature Communications|April 21, 2017
A genome-wide association study identifies six novel risk loci for primary biliary cholangitisFang Qiu, Ruqi Tang, Xianbo Zuo, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Journal of Autoimmunity|February 1, 2024
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitisRui Wang, Qiuxiang Lin, Zhonghua Lu, et al.
Journal of Autoimmunity|February 3, 2019
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?Chunyan Sun, Xiao Xiao, Li Yan, et al.
Nature Communications|March 28, 2023
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expressionYou Li, Zhiqiang Li, Ruiling Chen, et al.
Clinical Reviews in Allergy & Immunology|June 9, 2026
Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score DevelopmentHaoyu Wen, Yu Chen, Qiuxiang Lin, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapyYu Chen, Haoyu Wen, You Li, et al.
Imeta|March 3, 2025
Gut microbiota in treating inflammatory digestive diseases: Current challenges and therapeutic opportunitiesYongpeng Shi, Zeran Chen, Tingyu Fang, et al.
Hepatology (Baltimore, Md.)|February 20, 2022
Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1You Li, Ying Sun, Yanmin Liu, et al.
Nature Communications|April 21, 2017
A genome-wide association study identifies six novel risk loci for primary biliary cholangitisFang Qiu, Ruqi Tang, Xianbo Zuo, et al.
Pageof 20